Trials / Unknown
UnknownNCT03168048
Oncologic Therapy Support Via Means of a Dedicated Mobile App
Oncologic Therapy Support Via Means of a Dedicated Mobile App - a Prospective Feasibility Evaluation
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Heidelberg University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The present single-center prospective exploratory study, conducted at Heidelberg University Hospital, assesses the feasibility of introducing a concept for additional patient care based on a mobile application for patients undergoing radiotherapy. Patients presenting themselves for the irradiation of thoracic or pelvic tumors will be surveyed regarding general performance, treatment-related Quality of Life (QoL) and symptoms and their need to personally consult a physician on a treatment-daily basis by means of a mobile application. The primary endpoint of feasibility will be reached when 80% of the patients have successfully answered 80% of their respective questions scheduled for each treatment day. Furthermore, treatment-related patient satisfaction and diagnosis-related QoL is assessed by PSQ-18 and EORTC questionnaires at the end of radiotherapy and at the first follow-up.
Conditions
- Thoracic Neoplasm
- Pelvic Neoplasm
- Radiotherapy; Complications
- Oncologic Disorders
- Breast Cancer
- Satisfaction
- Quality of Life
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | mobile application | Oncologic therapy support by means of a mobile application |
Timeline
- Start date
- 2017-07-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2017-05-30
- Last updated
- 2017-05-30
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03168048. Inclusion in this directory is not an endorsement.